1) urapidil injection
乌拉地尔注射液
1.
Efficacy and safety of urapidil injection in treatment of severe essential hypertension;
乌拉地尔注射液治疗重度原发性高血压的疗效与安全性
2) urapidil hydrochloride injection
盐酸乌拉地尔注射液
1.
21mg of urapidil hydrochloride injection ( Lixiding injection, n = 60).
79mg,对照组用盐酸乌拉地尔注射液(利喜定注射液)平均为84。
3) Urapidil
乌拉地尔
1.
Determination of Urapidil by Flow Injection Chemiluminescence;
流动注射-化学发光法测定乌拉地尔
2.
Determination of Urapidil by HPLC;
新药乌拉地尔含量的高效液相色谱法测定
3.
Comparison of clinical efficacy between urapidil and other vasodilators in acute left heart failure;
乌拉地尔治疗急性左心衰竭与其它血管扩张剂疗效比较
4) Diltiazem intravenous fluid
地尔硫卓注射液
1.
Observation of lowing blood pressure effect of Diltiazem intravenous fluid in outburst hypertension during hemodyalysis treatment;
地尔硫卓注射液在血透治疗期间突发高血压的降压作用
5) Alprostadil Injection
前列地尔注射液
1.
OBJECTIVE To compare the equivalence and safety between reference preparation and test preparation of alprostadil injection in patients with chronic lower extremity arterial occlusive disease.
目的本试验旨在观察种市售前列地尔注射液在治疗下肢慢性动脉闭塞症的等效性和安全性。
2.
Objective: To investigate the clinical effect of Shengmai injection combined with alprostadil injection on diabetes peripheral neuropathy.
目的:观察生脉注射液联合前列地尔注射液治疗糖尿病周围神经病变的临床疗效。
补充资料：盐酸乌拉地尔
分子式：C20H30ClN5O3
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：抗高血压药。
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：抗高血压药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条